← back to search

Xiongwen Tang

BioReliance (United States) · US
Area of research
Oncology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Palliative Care and End-of-Life Issues, Pain Management and Opioid Use, Lung Cancer Research Studies, and Cancer Immunotherapy and Biomarkers.
h-index
16
citations
1,676
works
37
NIH funding
primary concept
Medicine
email

Recent publications

Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial
Nature Medicine 2024cited by 107position: middledoi
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma
JAMA 2023cited by 222position: middledoi
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial
Cancer Cell 2022cited by 558position: middledoi
Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)
Journal of Clinical Oncology 2022cited by 166position: middledoi
The Effect of a Translating Research into Practice (TRIP)-Cancer Intervention on Cancer Pain Management in Older Adults in Hospice
Pain Medicine 2012cited by 27position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Chris Forcucci · University of Iowa1 papers (2012–2012)Keela Herr · University of Iowa1 papers (2012–2012)Marita G. Titler · University of Iowa1 papers (2012–2012)Joseph E. Cavanaugh · University of Iowa1 papers (2012–2012)Perry G. Fine · University of Utah1 papers (2012–2012)John Swegle · University of Iowa1 papers (2012–2012)